• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Pediatric myopia and keratoconus: Key detection and treatment strategies

Publication
Article
Optometry Times JournalJuly digital edition 2023
Volume 15
Issue 07
Pages: 12, 15-16

Pediatric keratoconus is often more challenging to diagnose, resulting in treatment delay and vision loss.

Woman with child getting an eye exam

(Image credit:Adobestock/Seventyfour)

Myopia has long been defined as a dioptric diagnosis of refractive error. Because of the seemingly benign presentation, myopia has yet to be classified as a disease. Growing research, however, has supported and validated that the underlying etiology of myopia predominantly stems from axial elongation of the globe.1,2

The younger the age at which the onset of myopia occurs, the more rapid the progression of myopia. Because of its early onset, the potential odds of developing lifelong ocular complications can be significant in adulthood, which can be detrimental to overall ocular health.1,2 Myopia affected 30% of the global population in 2020. That percentage is estimated to rise to 50% by 2050, when 5 billion individuals
worldwide will likely develop myopia.3

Keratoconus is known as a bilateral, noninflammatory ectatic corneal disorder characterized by progressive stromal thinning, corneal irregularities, and permanent vision loss if left unmanaged. It is associated with progressive myopia. Currently, the estimated global prevalence in the general population is approximately 1 in 375 to 1 in 2000 individuals, depending on the testing used.4-6

Patients with keratoconus are generally younger, with male patients having a higher ratio of advanced keratoconus compared with female patients.6,7 Keratoconus has been reported in children with Down syndrome as young as 4 years.8 Distinct clinical signs, such as corneal steepening or thinning, Vogt striae (Figure 1), Fleischer ring, or Munson sign,9,10 may not manifest in the early stages in the pediatric population. Because of inadequate or inconclusive clinical signs, cases of keratoconus are largely underdiagnosed in pediatric patients.6,11 Corneal topographical analysis provides an earlier indication for which progression can be screened and monitored periodically.

Figure 1. Vogt striae in an adult keratoconic.(Image courtesy of Tracy L. Schroeder Swartz, OD, MS, FAAO)

Figure 1. Vogt striae in an adult keratoconic.(Image courtesy of Tracy L. Schroeder Swartz, OD, MS, FAAO)

At first glance, the nature of myopia may not seem to share similarities with keratoconus. Research suggests the onset and development of myopia may be implicated by different stages of corneal biomechanical variabilities. Decreased corneal stiffness was found in patients with progressing myopia.12,13 The intricate relationship between myopia and keratoconus may be more common than initially expected. A study investigated the association between keratoconus and axial myopia.14

Biometric parameters were compared between eyes diagnosed with keratoconus and eyes with emmetropia serving as controls. Significantly greater axial length was found in eyes with keratoconus compared with eyes with emmetropia (23.97 vs 23.21 mm; P < .001). A similar pattern was noted for posterior segment length between the 2 groups (16.54 vs 15.99 mm; P < .001). A strong positive association between posterior segment length and spherical equivalent refractive error suggested that keratoconus likely shares some levels of pathophysiological etiology with axial myopia.

Practical considerations may be warranted for patients with keratoconus and myopia undergoing surgical interventions, such as penetrating keratoplasty (PK), because longer axial lengths of eyes with keratoconus may affect postoperative refractive outcomes.15 Nevertheless, the development of axial myopia was shown to continue upon postoperative PK for keratoconus, suggestive of possible independent pathways upon the initial onset.16

Clinicians following young patients with myopia using myopia control programs see patients regularly and are likely to note changes in manifest refraction, contact lens fitting parameters, corneal topography, and best corrected vision that may indicate keratoconus. It is important to keep early signs of keratoconus in mind to identify patients prior to vision loss. Pediatric keratoconus shares many signs and symptoms of adult keratoconus.

However, it is more progressive at a younger age17 and more aggressive than adult keratoconus.6,10 Al Suhaibani et al reported that the severity of keratoconus is inversely associated with the age of onset.18 Léoni-Mesplié et
al assessed 216 patients with keratoconus, including 49 patients 15 years or younger.19 At initial diagnosis, 27.8% of the pediatric group had stage IV keratoconus using the Amsler-Krumeich classification whereas 7.8% in the adult group had stage IV keratoconus.

Findings from a retrospective study by El-Khoury et al found that 541 patients received a diagnosis of keratoconus over a 5-year period. Sixteen were children younger than 14 years who presented for routine care (n=1 patient), allergic conjunctivitis (n=3), reduced vision (n=10), and corneal hydrops (n = 2).20 Olivo-Payne et al suggested that children have a higher risk of acute corneal hydrops, leading to an increased need for corneal transplantation to improve vision.11 Early detection and timely treatments are paramount to halt progression and prevent severe vision impairment for children.

Key clinical indicators of developing keratoconus in children include higher average central corneal keratometry (vs periphery), increased posterior corneal elevation, and thinner corneal thickness.10 Keratoconus in children may manifest differently than in adults. The cornea ectasia location was reported to be located more centrally among pediatric patients.21 In these cases, the extent of irregular astigmatism is generally less pronounced, so visual acuity is not significantly affected and should not be used as an indicator. Young patients tend to show few symptoms until the keratoconus deteriorates bilaterally.

Look out for atopic signs and symptoms

Keratoconus is generally more prevalent in those with atopic eye disorders, including vernal keratoconjunctivitis (VKC) and seasonal allergic conjunctivitis (SAC).22 Gupta et al evaluated patients with keratoconus younger than 18 years using visual acuity, corneal topography, aberrometry, and biomechanical and confocal microscopy.23One hundred sixteen eyes of 62 consecutive patients (mean age ± SD, 14.7 ± 2.77 years; range, 8-18 years) were studied; 88% of patients were male, and 92% demonstrated bilateral disease. Although systemic associations were identified in 9.7%
of patients, ocular associations were identified in 66.3%, including VKC in 58.6%. Among eyes with VKC, 29 of 68 eyes (46%) were in stage IV of the disease vs 25% of eyes with no VKC (P=.004).

Naderan et al prospectively investigated allergic diseases among patients with keratoconus.24 They evaluated 885 patients with keratoconus, comparing them with 1526 control patients and looking for various allergic diseases. They found significantly thinner and steeper corneas in patients with keratoconus and VKC or SAC compared with nonallergic patients with KC. They recommended this subpopulation be followed more closely.

Five hundred thirty cases of VKC were studied in Pakistan.25Corneal complications occurred in 259 patients, including 48 patients with keratoconus (41 male, 7 female). Thirty-seven of 48 patients were aged between 10 and 30 years. Six patients developed acute hydrops, with 1 bilateral case.

Results from other studies found that patients with VKC or SAC displayed significantly distinct corneal and biomechanical features, notably steeper and thinner corneas compared with the nonallergic group with keratoconus.26 This suggests that this subpopulation experiencing atopic disease is particularly susceptible to severe keratoconus.

Not surprisingly, younger patients with VKC or SAC tend to show higher behavioral dependency of eye rubbing to alleviate the symptoms. Meta-analyses and reviews revealed consistent associations with the progression of keratoconus.27,28

Chronic corneal epithelial degradation from matrix metalloproteinases (MMPs) have been blamed for keratoconus progression.29,30 MMP levels are often elevated because of allergic and vernal conjunctivitis. As a result, chronic corneal epithelial degradation secondary to MMP level elevation has been considered an etiology of rapid progression of keratoconusin children.

In addition, corneal ectasia is likely associated with IgE-driven cascade events that trigger extracellular matrix remodeling and chronic inflammatory reaction on the cornea. Patients experiencing VKC or SAC need to be monitored using corneal topography to identify keratoconus in early stages.

Pediatric keratoconus is often more challenging to diagnose, resulting in treatment delay and vision loss. For mild to moderate ectasia, corneal cross-linking is recommended to halt progression. Scleral lenses are a great tool for visual rehabilitation and may be used for pediatric patients as young as 7 months with remarkable outcomes.31,32 For severe cases in which keratoconus and corneal scarring is involved, corneal keratoplasty is likely warranted to aid visual rehabilitation and preserve vision.


References
1. Du R, Xie S, Igarashi-Yokoi T, et al. Continued increase of axial length and its risk factors in adults with high myopia. JAMA Ophthalmol. 2021;139(10):1096-1103. doi:10.1001/jamaophthalmol.2021.3303

2. Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci.2020;61(4):49. doi:10.1167/
iovs.61.4.49

3. Sankaridurg P, Tahhan N, Kandel H, et al. IMI impact of myopia. Invest
Ophthalmol Vis Sci. 2021;62(5):2. doi:10.1167/iovs.62.5.2

4. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42(4):297-319.
doi:10.1016/s0039-6257(97)00119-7

5. Hashemi H, Heydarian S, Hooshmand E, et al. The prevalence and risk
factors for keratoconus: a systematic review and meta-analysis. Cornea.
2020;39(2):263-270. doi:10.1097/ICO.0000000000002150

6. Buzzonetti L, Bohringer D, Liskova P, Lang S, Valente P. Keratoconus
in children: a literature review. Cornea. 2020;39(12):1592-1598.
doi:10.1097/ICO.0000000000002420

7. Yang K, Gu Y, Xu L, et al. Distribution of pediatric keratoconus by
different age and gender groups. Front Pediatr. 2022;10:937246.
doi:10.3389/fped.2022.937246

8. Sabti S, Tappeiner C, Frueh BE. Corneal cross-linking in a 4-year-old
child with keratoconus and down syndrome. Cornea. 2015;34(9):1157-
1160. doi:10.1097/ICO.0000000000000491

9. Mukhtar S, Ambati BK. Pediatric keratoconus: a review of the
literature. Int Ophthalmol. 2018;38(5):2257-2266. doi:10.1007/s10792-
017-0699-8

10. Anitha V, Vanathi M, Raghavan A, Rajaraman R, Ravindran M, Tandon
R. Pediatric keratoconus - current perspectives and clinical challenges.
Indian J Ophthalmol. 2021;69(2):214-225. doi:10.4103/ijo.IJO_1263_20

11. Olivo-Payne A, Abdala-Figuerola A, Hernandez-Bogantes E, Pedro-
Aguilar L, Chan E, Godefrooij D. Optimal management of pediatric
keratoconus: challenges and solutions. Clin Ophthalmol. 2019;13:1183-
1191. doi:10.2147/OPTH.S183347

12. Sedaghat MR, Momeni-Moghaddam H, Azimi A, et al. Corneal
biomechanical properties in varying severities of myopia. Front Bioeng
Biotechnol. 2021;8:595330. doi:10.3389/fbioe.2020.595330

13. Han F, Li M, Wei P, Ma J, Jhanji V, Wang Y. Effect of biomechanical
properties on myopia: a study of new corneal biomechanical
parameters. BMC Ophthalmol. 2020;20(1):459. doi:10.1186/s12886-
020-01729-x

14. Touzeau O, Scheer S, Allouch C, Borderie V, Laroche L. Relation entre
le kératocône et la myopie axile [The relationship between keratoconus
and axial myopia]. J Fr Ophtalmol. 2004;27(7):765-771. doi:10.1016/
s0181-5512(04)96211-0

15. Ernst BJ, Hsu HY. Keratoconus association with axial myopia:
a prospective biometric study. Eye Contact Lens. 2011;37(1):2-5.
doi:10.1097/ICL.0b013e3181fb2119

16. Tuft SJ, Fitzke FW, Buckley RJ. Myopia following penetrating
keratoplasty for keratoconus. Br J Ophthalmol. 1992;76(11):642-645.
doi:10.1136/bjo.76.11.642

17. Meyer JJ, Gokul A, Vellara HR, McGhee CNJ. Progression
of keratoconus in children and adolescents. Br J Ophthalmol.
2023;107(2):176-180. doi:10.1136/bjophthalmol-2020-316481

18. Al Suhaibani AH, Al-Rajhi AA, Al-Motowa S, Wagoner MD. Inverse
relationship between age and severity and sequelae of acute corneal
hydrops associated with keratoconus. Br J Ophthalmol. 2007;91(7):984-
985. doi:10.1136/bjo.2005.085878

19. Léoni-Mesplié S, Mortemousque B, Touboul D, et al. Scalability and
severity of keratoconus in children. Am J Ophthalmol. 2012;154(1):56-
62.e1. doi:10.1016/j.ajo.2012.01.025

20. El-Khoury S, Abdelmassih Y, Hamade A, et al. Pediatric keratoconus
in a tertiary referral center: incidence, presentation, risk factors, and
treatment. J Refract Surg. 2016;32(8):534-541. doi:10.3928/108159
7X-20160513-01

21. Soeters N, van der Valk R, Tahzib NG. Corneal cross-linking for
treatment of progressive keratoconus in various age groups. J Refract
Surg. 2014;30(7):454-460. doi:10.3928/1081597X-20140527-03

22. Cingu AK, Cinar Y, Turkcu FM, et al. Effects of vernal and allergic conjunctivitis on severity of keratoconus. Int J Ophthalmol.
2013;6(3):370-374. doi:10.3980/j.issn.2222-3959.2013.03.21

23. Gupta Y, Saxena R, Jhanji V, et al. Management outcomes in pediatric keratoconus: childhood keratoconus study. J Ophthalmol. 2022;2022:4021288. doi:10.1155/2022/4021288

24. Naderan M, Rajabi MT, Zarrinbakhsh P, Bakhshi A. Effect of allergic diseases on keratoconus severity. Ocul Immunol Inflamm. 2017;25(3):418-423. doi:10.3109/09273948.2016.1145697

25. Khan MD, Kundi N, Saeed N, Gulab A, Nazeer AF. Incidence of keratoconus in spring catarrh. Br J Ophthalmol. 1988;72(1):41-43. doi:10.1136/bjo.72.1.41

26. Gupta Y, Sharma N, Maharana PK, et al. Pediatric keratoconus: topographic, biomechanical and aberrometric characteristics. Am J
Ophthalmol. 2021;225:69-75. doi:10.1016/j.ajo.2020.12.020

27. Sahebjada S, Al-Mahrouqi HH, Moshegov S, et al. Eye rubbing in the aetiology of keratoconus: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021;259(8):2057-2067. doi:10.1007/
s00417-021-05081-8

28. Najmi H, Mobarki Y, Mania K, et al. The correlation between keratoconus and eye rubbing: a review. Int J Ophthalmol. 2019;12(11):1775-1781. doi:10.18240/ijo.2019.11.17

29. Kim WJ, Rabinowitz YS, Meisler DM, Wilson SE. Keratocyte apoptosis associated with keratoconus. Exp Eye Res. 1999;69(5):475-481.
doi:10.1006/exer.1999.0719

30. Kao WW, Vergnes JP, Ebert J, Sundar-Raj CV, Brown SI. Increased collagenase and gelatinase activities in keratoconus. Biochem Biophys
Res Commun. 1982;107(3):929-936. doi:10.1016/0006-291x(82)90612-x

31. Severinsky B, Lenhart P. Scleral contact lenses in the pediatric population-indications and outcomes. Cont Lens Anterior Eye. 2022;45(3):101452. doi:10.1016/j.clae.2021.101452

32. Gungor I, Schor K, Rosenthal P, Jacobs DS. The Boston Scleral Lens in the treatment of pediatric patients. J AAPOS. 2008;12(3):263-267. doi:10.1016/j.jaapos.2007.11.008

Kevin Chan, OD, MS, FAAO, is the senior clinical director of Treehouse Eyes and currently serves as a professional affairs consultant for Johnson & Johnson Vision and Essilor’s Myopia Taskforce. Notably, Chan has starred in the renowned TEDx talk titled, “Myopia - Global Epidemic.” kevin.chan@treehouseeyes.com

Tracy L. Schroeder Swartz, OD, MS, FAAO, Dipl ABO is in group optometric practice in Madison, AL. tracysswartz@hotmail.com

Related Videos
Jessica Steen, OD, FAAO, discusses systemic medication and ocular adverse effects at Vision Expo East 2024
At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.
Brujic at Rinsada Booth at Vision Expo East 2024
Dr Brianna Rhue, OD, FAAO, FSLS chat about her upcoming presentation at Vision Expo East 2024
R Tracy Williams, OD, FAAO, tells his favorite stories as a team optometrist for the Chicago Bulls, White Sox
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
Mila Ioussifova, OD, FAAO
Tracy Doll, OD, FAAO
© 2024 MJH Life Sciences

All rights reserved.